These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 17152015)

  • 1. Baseline mycobacterial immune responses in HIV-infected adults primed with bacille Calmette-Guérin during childhood and entering a tuberculosis booster vaccine trial.
    Matee M; Lahey T; Vuola JM; Mtei L; Cole BF; Bakari M; Arbeit RD; Horsburgh CR; Pallangyo K; von Reyn CF
    J Infect Dis; 2007 Jan; 195(1):118-23. PubMed ID: 17152015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocyte proliferation to mycobacterial antigens is detectable across a spectrum of HIV-associated tuberculosis.
    Lahey T; Matee M; Mtei L; Bakari M; Pallangyo K; von Reyn CF
    BMC Infect Dis; 2009 Feb; 9():21. PubMed ID: 19236695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity of an inactivated mycobacterial vaccine for the prevention of HIV-associated tuberculosis: a randomized, controlled trial.
    Vuola JM; Ristola MA; Cole B; Järviluoma A; Tvaroha S; Rönkkö T; Rautio O; Arbeit RD; von Reyn CF
    AIDS; 2003 Nov; 17(16):2351-5. PubMed ID: 14571187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon γ responses to mycobacterial antigens protect against subsequent HIV-associated tuberculosis.
    Lahey T; Sheth S; Matee M; Arbeit R; Horsburgh CR; Mtei L; Mackenzie T; Bakari M; Vuola JM; Pallangyo K; von Reyn CF
    J Infect Dis; 2010 Oct; 202(8):1265-72. PubMed ID: 20812851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of tuberculosis in Bacille Calmette-Guérin-primed, HIV-infected adults boosted with an inactivated whole-cell mycobacterial vaccine.
    von Reyn CF; Mtei L; Arbeit RD; Waddell R; Cole B; Mackenzie T; Matee M; Bakari M; Tvaroha S; Adams LV; Horsburgh CR; Pallangyo K;
    AIDS; 2010 Mar; 24(5):675-85. PubMed ID: 20118767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of BCG immunization and human immunodeficiency virus infection on dual skin test reactions to purified protein derivative and Mycobacterium avium sensitin among adults in Zambia.
    Waddell RD; von Reyn CF; Baboo KS; Mwinga A; Chintu C; Zumla A
    Int J Tuberc Lung Dis; 1999 Mar; 3(3):255-60. PubMed ID: 10094328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-gamma production by mononuclear cells in Bacille Calmette-Guérin-revaccinated healthy volunteers predicted long-term antimycobacterial responses in a randomized controlled trial.
    Oliveira ES; Marinho JM; Barbosa T;
    Vaccine; 2013 Aug; 31(37):3778-82. PubMed ID: 23684832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune responses of white-tailed deer (Odocoileus virginianus) to Mycobacterium bovis BCG vaccination.
    Waters WR; Palmer MV; Whipple DL; Slaughter RE; Jones SL
    J Wildl Dis; 2004 Jan; 40(1):66-78. PubMed ID: 15137490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and immunogenicity of a five-dose series of inactivated Mycobacterium vaccae vaccination for the prevention of HIV-associated tuberculosis.
    Waddell RD; Chintu C; Lein AD; Zumla A; Karagas MR; Baboo KS; Habbema JD; Tosteson AN; Morin P; Tvaroha S; Arbeit RD; Mwinga A; von Reyn CF
    Clin Infect Dis; 2000 Jun; 30 Suppl 3():S309-15. PubMed ID: 10875806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consequence of prior exposure to environmental mycobacteria on BCG vaccination and diagnosis of tuberculosis infection.
    Thom M; Howard C; Villarreal-Ramos B; Mead E; Vordermeier M; Hope J
    Tuberculosis (Edinb); 2008 Jul; 88(4):324-34. PubMed ID: 18329343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of a protective whole cell mycobacterial vaccine in HIV-infected adults: a phase III study in Tanzania.
    Lahey T; Arbeit RD; Bakari M; Horsburgh CR; Matee M; Waddell R; Mtei L; Vuola JM; Pallangyo K; von Reyn CF
    Vaccine; 2010 Nov; 28(48):7652-8. PubMed ID: 20875492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cytokine response to bacille Calmette Guérin vaccination in South India.
    Das SD; Narayanan PR; Kolappan C; Colston MJ
    Int J Tuberc Lung Dis; 1998 Oct; 2(10):836-43. PubMed ID: 9783532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal bacille calmette-Guérin vaccination of humans inhibits delayed-type hypersensitivity to purified protein derivative but induces mycobacteria-specific interferon-gamma responses.
    Hoft DF; Brown RM; Belshe RB
    Clin Infect Dis; 2000 Jun; 30 Suppl 3():S217-22. PubMed ID: 10875787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular immune responses to mycobacteria in healthy and human immunodeficiency virus-positive subjects in the United States after a five-dose schedule of Mycobacterium vaccae vaccine.
    von Reyn CF; Marsh BJ; Waddell R; Lein AD; Tvaroha S; Morin P; Modlin JF
    Clin Infect Dis; 1998 Dec; 27(6):1517-20. PubMed ID: 9868670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human immunodeficiency virus (HIV) infection during pregnancy induces CD4 T-cell differentiation and modulates responses to Bacille Calmette-Guérin (BCG) vaccine in HIV-uninfected infants.
    Miles DJ; Gadama L; Gumbi A; Nyalo F; Makanani B; Heyderman RS
    Immunology; 2010 Mar; 129(3):446-54. PubMed ID: 20002789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacille Calmette-Guérin vaccination enhances human gamma delta T cell responsiveness to mycobacteria suggestive of a memory-like phenotype.
    Hoft DF; Brown RM; Roodman ST
    J Immunol; 1998 Jul; 161(2):1045-54. PubMed ID: 9670986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High rates of clinical and subclinical tuberculosis among HIV-infected ambulatory subjects in Tanzania.
    Mtei L; Matee M; Herfort O; Bakari M; Horsburgh CR; Waddell R; Cole BF; Vuola JM; Tvaroha S; Kreiswirth B; Pallangyo K; von Reyn CF
    Clin Infect Dis; 2005 May; 40(10):1500-7. PubMed ID: 15844073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization with heat-killed Mycobacterium bovis bacille Calmette-Guerin (BCG) in Eurocine L3 adjuvant protects against tuberculosis.
    Haile M; Schröder U; Hamasur B; Pawlowski A; Jaxmar T; Källenius G; Svenson SB
    Vaccine; 2004 Mar; 22(11-12):1498-508. PubMed ID: 15063575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and immunogenicity of an inactivated whole cell tuberculosis vaccine booster in adults primed with BCG: A randomized, controlled trial of DAR-901.
    von Reyn CF; Lahey T; Arbeit RD; Landry B; Kailani L; Adams LV; Haynes BC; Mackenzie T; Wieland-Alter W; Connor RI; Tvaroha S; Hokey DA; Ginsberg AM; Waddell R
    PLoS One; 2017; 12(5):e0175215. PubMed ID: 28498853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disseminated tuberculosis in human immunodeficiency virus infection: ineffective immunity, polyclonal disease and high mortality.
    von Reyn CF; Kimambo S; Mtei L; Arbeit RD; Maro I; Bakari M; Matee M; Lahey T; Adams LV; Black W; Mackenzie T; Lyimo J; Tvaroha S; Waddell R; Kreiswirth B; Horsburgh CR; Pallangyo K
    Int J Tuberc Lung Dis; 2011 Aug; 15(8):1087-92. PubMed ID: 21740673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.